A new complication after receiving the MRNA12-73 (Moderna) vaccine for Coronavirus disease (COVID-19) in Iran
A case report
Keywords:
MRNA12-73 vaccine, corona pandemic (SARS-CoV-2); lumbar radiculopathy, puffy hands, vaccine side effectsAbstract
Introduction: The recent pandemic of the SARS-CoV-2 virus has significantly increased the mortality and disability burden in many people worldwide. Several effective vaccines have been introduced since the outbreak of the coronavirus. These vaccines work through several different immunization pathways to create effective immunity. In this respect, there have been no reports of patients with symptoms of lumbar radiculopathy and puffiness of the hands after receiving corona vaccines. This article presents a clinical case report of these symptoms after receiving the MRNA12-73 (Moderna) vaccine. Overall, finding effective, low-complication, and safe solutions against this virus can have a beneficial effect in reducing the side effects of the Corona vaccine and maintaining the health and lives of people. Case history: A 73-year-old male patient developed lumbar radiculopathy and puffy hands after receiving the corona (COVID-19) vaccine. He was infected with COVID-19 about 60 days after receiving the MRNA12-73 (Moderna) vaccine. Conclusion: Attention to the occurrence of any side effects after injecting corona vaccines requires additional studies. It is also important to follow up on any clinical signs of suspected coronary involvement, even after the vaccination.
Downloads
References
Li Y-D, Chi W-Y, Su J-H, Ferrall L, Hung C-F, Wu T-C. Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of biomedical science. 2020;27(1):1-23.
Kamali Aghdam M, Jafari N, Eftekhari K. Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report. Infectious Diseases. 2020;52(6):427-9.
Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Fotiou D, Migkou M, Tzanninis I-G, et al. Emerging treatment strategies for COVID-19 infection. Clinical and experimental medicine. 2021;21(2):167-79.
Phillis A. A COVID-19 vaccine—dare to dream. British Journal of Community Nursing. 2020;25(12):2-7.
Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nature reviews. Drug discovery. 2020;19(5):305-6.
Alghamdi A, Ibrahim A, Almutairi R, Joseph M, Alghamdi G, Alhamza A. A cross-sectional survey of side effects after COVID-19 vaccination in Saudi Arabia: Male versus female outcomes. Journal of Advanced Pharmacy Education & Research. 2021;11(2):51-56.
Siyal FJ, Shaikh ZA, Ahmed SZ, Shahid MA, Agha F, Khoso M, Unar AA, Unar K, Saleem R, Shahani MP. Anxiety among COVID-19 physicians during the pandemic in the health care center of the rural region. Archives of Pharmacy Practice. 2020 Oct 1;11(4):91-3.
Alamoudi MO, Bakrshoom YF, Bakrshoom SF, Abdel-Rahman EH, Al-malky HS, Zeid IM. Therapeutics and Possible Vaccine Used to Treat Covid-19: a Review. International Journal of Pharmaceutical and Phytopharmacological Research. 2020 Aug;10(4):36-43.
Kadali RAK, Janagama R, Peruru S, Gajula V, Madathala RR, Chennaiahgari N, et al. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. Journal of Medical Virology. 2021;93(7):4420-9.
Ali K, Berman G, Zhou H, Deng W, Faughnan V, Coronado-Voges M, et al. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. New England Journal of Medicine. 2021.
McNeil M, Weintraub E, Duffy J, Sukumaran L, Jacobsen S, Klein N, et al. Risk of anaphylaxis after vaccination in children and adults. The Journal of allergy and clinical immunology. 2015;137.
Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y. ASIA syndrome and endocrine autoimmune disorders. Best Practice & Research Clinical Endocrinology & Metabolism. 2020;34(1):101412.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine. 2021;384(5):403-16.
Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus research. 2020:198114.
Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. Journal of Public Health. 2021;43(3):445-9.
Vergara RJD, Sarmiento PJD, Lagman JDN. Building public trust: a response to COVID-19 vaccine hesitancy predicament. Journal of Public Health. 2021;43(2):e291-e2.
Soiza RL, Scicluna C, Thomson EC. Efficacy and safety of COVID-19 vaccines in older people. Age and Ageing. 2021;50(2):279-83.
Sampath V, Rabinowitz G, Shah M, Jain S, Diamant Z, Jesenak M, et al. Vaccines and Allergic reactions: the past, the current COVID‐19 pandemic, and future perspectives. Allergy. 2021.
COVID C, Team R. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 Vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report. 2021;70(4):125.
Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. Morbidity and Mortality Weekly Report. 2021;70(8):283.
Niebel D, Wilhelmi J, De Vos L, Ziob J, Jaschke K, Bieber T, et al. Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon? The Journal of Dermatology.n/a(n/a).
!!! INVALID CITATION !!! {Blumenthal, 2021 #14;Baden, 2021 #10}.
Chantalat L, Simon M, Fourgeaud C, Vignes S. Puffy hand syndrome: A little-known diagnosis. La Revue de Medecine Interne. 2020.
Austria QM, Lelli GJ, Segal KL, Godfrey KJ. Transient Eyelid Edema Following COVID-19 Vaccination. Ophthalmic Plastic and Reconstructive Surgery. 2021;37(5):501.
Banerji A, Wickner PG, Saff R, Stone Jr CA, Robinson LB, Long AA, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and approach. The Journal of Allergy and Clinical Immunology: In Practice. 2020.
Suwija, N., Suarta, M., Suparsa, N., Alit Geria, A.A.G., Suryasa, W. (2019). Balinese speech system towards speaker social behavior. Humanities & Social Sciences Reviews, 7(5), 32-40. https://doi.org/10.18510/hssr.2019.754
Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
